Teriflunomide: A Novel Oral Treatment for Relapsing Multiple Sclerosis
April 2014
in “
Expert Opinion on Pharmacotherapy
”
Studysummary This review discusses the pharmacological profile of teriflunomide for treating relapsing multiple sclerosis, highlighting its safety and effectiveness in reducing relapses and slowing disability progression, though direct comparisons with other oral medications are lacking.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer